000 02956nam a2200277 a 4500
001 vtls000093267
003 KUKTEM
005 20251125103017.0
008 160111t2015 my da f b 000 0 eng d
020 _aOPE0001051(Local)
039 9 _a201905291500
_bzairi
_c201602011531
_dasma
_y201601111630
_zepul
040 _aUMP
090 _aQK861 .K46 2015
100 0 _aKhozirah Shaari
245 1 0 _aDiscovering future cures from phytochemistry to metabolomics /
_cKhozirah Shaari
260 _aSerdang, Selangor :
_bUPM Press,
_c2015
300 _a73 p. :
_bill. (some col.) ;
_c23 cm.
490 1 _aInaugural lecture series
504 _aIncludes bibliographical references
520 8 _aEukaryotes such as higher plants have evolved to produce a diverse range of low-molecular-weight compounds known as secondary metabolites or phytochemicals, that can be used as food and feed additives, flavours, fragrances, cosmetics, agrochemicals and pharmaceuticals. The chemical diversity of plants is more complex than any chemical library made by humans, and the plant kingdom therefore represents an enormous reservoir of valuable molecules just waiting to be discovered. There are approximately 298,000 species of higher plants, less than 10% of which have been chemically characterized to any extent. The majority of plant species are found in tropical rain forests. Extracts and infusions containing natural products from plants have historically been a major source of pharmaceutical ingredients, often comprising mixtures of several bioactive compounds with complex synergistic effects. The first secondary metabolite isolated from plants was morphine (over 200 years ago) and many other natural compounds have since become important pharmaceuticals in modern society. It is often difficult to find synthetic substitutes with the same efficacy and specificity as natural compounds. Consequently, molecules derived from plants make up a sizeable proportion of current high-value drugs, and also provide many new lead compounds for industrial applications. Many companies are undergoing a renaissance in their interest in plant-derived compounds, especially the pharmaceutical industry looking for new drugs, and the cosmetics industry which uses plant extracts, oils and even plant cell cultures in some products. The high structural diversity and complexity of secondary metabolites still pose technical challenges for a phytochemist since the chemical characteristics of the plant compounds vary to a very high degree, for example in the degree of polarity and solubility. Typically such compounds accumulate at low levels in plant tissues and production is strongly correlated to specif
650 0 _aPhytochemicals
650 0 _aBotanical chemistry
830 0 _aInaugural lecture series
999 _aVIRTUA40
_c81526
_d81532
999 _aVTLSSORT0080*0200*0400*0900*1000*2450*2600*3000*4900*5040*5200*5410*6500*6501*8300*9992